期刊文献+

甲状腺微小癌淋巴结转移影响因素分析 被引量:3

Lymph Node Metastasis in Thyroid Microcarcinoma: Analysis of Influencing Factors
下载PDF
导出
摘要 目的探讨甲状腺微小癌淋巴结转移的影响因素及临床应用价值。方法回顾性收集2003年1月~2008年12月在我院行手术治疗的96例甲状腺微小癌患者,根据是否发生淋巴结转移分为转移组28例和未转移组68例,通过单因素及多因素Logistic回归分析进行研究。结果本研究的TMC发生淋巴结转移率为29.2%(28/96);通过诊断试验ROC分析发现肿瘤直径0.6cm为其最佳临界值,肿瘤直径(OR=3.717)和甲状腺被膜侵犯(OR=3.459)因素对淋巴结转移的影响均有统计学意义。结论 TMC患者具有一定比例的颈部淋巴结转移率,尤其是肿瘤最大直径≥0.6cm以及甲状腺被膜受侵犯患者,行择区性淋巴结清扫术是有效的治疗方法。 Objective To analyze the clinical factors influencing on lymph node metastasis in thyroid micmcarcinoma(TMC). Methods The retrospective collection of 96 cases of TMC receiving operations from Jan 2003 to Dec 2008 was carried out. According to whether metastasis happened,96 cases were divided into two groups,metastasis group (28cases in it)and nonmetastasis group (68cases in it),and single factor and muhifactorial Logistic Regression analysis was used. Results The lymph node metastasis rate of TMC patients was 29.2%(28/96). We defined the optimal critical value(0.6cm)of tumor diameter by using diagnostic test ROC analysis, tumor diameter(OR=3.717)and thyroid capsule invasion (OR=3.459), with impact on lymph node metastasis. Conclusion The TMC patients have a certain tendency to metastasize, especially in the maximal tumor diameter≥ 0.6cm and the thyroid capsule invasion, and the selective lymph node dissection is an effective treatment.
出处 《中国现代医生》 2010年第30期18-20,共3页 China Modern Doctor
关键词 甲状腺微小癌 淋巴结 淋巴结转移 Thyroid mi a Lymph node Lymph node metastasis Risk factors
  • 相关文献

参考文献12

  • 1Ronald AD,Rieardo Vl,philipp UH,et al. World Health Organization Classification of Turnouts,Pathology and Genetics of Tumours of Endocrine Organs[J]. Lyon,France:International Agency for Research on Cancer (IARC), 2004,1 : 49-66.
  • 2Ito Y,Tomoda C,Uruno T,et al. Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid [J]. World J Surg,2006,30(1 ):91-99.
  • 3胡建生,陈培辉.23例甲状腺微小癌的临床病理分析[J].中国医师进修杂志(外科版),2009,32(3):61-63. 被引量:5
  • 4徐雅男,王家东.甲状腺乳头状微小癌淋巴结转移相关因素分析[J].临床耳鼻咽喉头颈外科杂志,2007,21(15):679-682. 被引量:19
  • 5李日增,周宏,潘黎静.甲状腺微小癌预后因素分析[J].实用医学杂志,2009,25(21):3653-3655. 被引量:7
  • 6Kim TY,Kiln WB,Song JY,et al. The BRA Fmumdonisnot associated widl poor prognostic factors in Korean patients with conventional papillary thyroid microcalcinoma [J]. Clin Endocrinol(Oxf), 2005,63 (5) : 588-593.
  • 7Trovisco V,Soares P,Preto A,et al. Type and prevalence of BRAF mumtiom ale closely associated widl papillary thyroid carcinoma histotype and patients age but not with tumour agnessiveness [J]. Virchows Arch, 2005,446(6) : 589-595.
  • 8Sedliarou I,Saenko V,Lantsov D,et al. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcald noma[J]. Im J Oncol, 2004,25 (6) : 1729-1735.
  • 9Roti E,Rsssi R,Trasforini G,et al. Clinical and histological characteristics of papillary thyroid microcarcinoma:resuhs of a retrospective study in 243 patients[J]. J Clin Endocrinol Metab,2006,91(6):2171-2178.
  • 10Chow SM, Law SC, Chart JK, et al. Papillary mieroeareinoma of the thyroid prognositic significance of lymph node metastasis and multifocality [J]. Cancer, 2003,98 ( 1 ) : 31-40.

二级参考文献41

共引文献67

同被引文献38

  • 1侯刚,李道胜,李宁,叶红,王青,李静文.甲状腺微小癌的快速冷冻切片诊断及免疫组化分析[J].诊断病理学杂志,2007,14(2):129-131. 被引量:13
  • 2叶国超,袁文斌,刘力伟.中央区颈淋巴结清扫术对甲状腺微小癌的治疗价值[J].中华肿瘤杂志,2007,29(5):396-398. 被引量:16
  • 3FRANSSILA K O, HARACH H R. Occult papillary carcinoma of the thyroid in children and young adults. A systemic autopsy study in Finland [J]. Cancer,1986,58:715-719.
  • 4ROTI E, DEGLI UBERTI E C, BONDANELLI M, et al. Thyroid papillary microcarcinoma: a descriptive and mela-analysis study[J]. Eur J Endocrinol,2008, 159:659-673.
  • 5GOUGH 1 R, WILKINSON D. Total thyroidectomy for management of thyroid disease[J]. World J Surg, 2000,24: 962- 965.
  • 6WADA N,DUH Q Y,SUGINO K,et al. Lymph node metasis from 259 papillary thyroid microcarinoma[J]. Ann Surg,2003,237 : 399- 407.
  • 7NOGUCHI S, YAMASHITA H, MURAKAMI N, et al. Small carcinomas of the thyroid., a long-term fol- low-up of 867 patients[J]. Arch Surg, 1996, 131: 187-191.
  • 8KHOO M L,ASA S L,WlTTERICK U,et al. Thy- roid calciffcation and its association with thyroid car- cinoma[J]. Head Neck, 2002,24 : 651 - 655.
  • 9SIPOS J A. Advances in ultrasound for the diagnoses and management of thyroid cancer[J]. Thyroid,2009, 19:1363-1869.
  • 10PAVELIC K, DEDIVITIS R A, K APITANOVIC S, et al. Molecular genetic alterations of FH1T and p53 genes in benign and malignant thyroid gland lesions [J]. Mulat Res,2006,599:45-57.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部